Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 505 entries
Sorted by: Best Match Show Resources per page
Professional growth. Support, do you give it? Do you get it?.

Nursing

Metzger N.
PMID: 3846151
Nursing. 1985 May;15(5):97-101. doi: 10.1097/00152193-198505000-00021.

No abstract available.

Cite
Metzger N. Professional growth. Support, do you give it? Do you get it?. Nursing. 1985;15(5):97-101doi: 10.1097/00152193-198505000-00021.
Metzger, N. (1985). Professional growth. Support, do you give it? Do you get it?. Nursing, 15(5), 97-101. https://doi.org/10.1097/00152193-198505000-00021
Metzger, N. "Professional growth. Support, do you give it? Do you get it?." Nursing vol. 15,5 (1985): 97-101. doi: https://doi.org/10.1097/00152193-198505000-00021
Metzger N. Professional growth. Support, do you give it? Do you get it?. Nursing. 1985 May;15(5):97-101. doi: 10.1097/00152193-198505000-00021. PMID: 3846151.
Copy Download .nbib Format: NLM
[Progress in the technic of orbital phlebography].

Journal de radiologie, d'electrologie, et de medecine nucleaire

Metzger J, Aron D, Ramée A, Hélias A.
PMID: 5498169
J Radiol Electrol Med Nucl. 1970 Jan-Feb;51(1):60-2.

No abstract available.

Cite
Metzger J, Aron D, Ramée A, et al. Progrès dans la technique de la phlébographie orbitaire. [Progress in the technic of orbital phlebography]. J Radiol Electrol Med Nucl. 1970;51(1):60-2
Metzger, J., Aron, D., Ramée, A., & Hélias, A. (1970). Progrès dans la technique de la phlébographie orbitaire. [Progress in the technic of orbital phlebography]. Journal de radiologie, d'electrologie, et de medecine nucleaire, 51(1), 60-2.
Metzger, J, et al. "Progrès dans la technique de la phlébographie orbitaire." [Progress in the technic of orbital phlebography]. Journal de radiologie, d'electrologie, et de medecine nucleaire vol. 51,1 (1970): 60-2.
Metzger J, Aron D, Ramée A, Hélias A. Progrès dans la technique de la phlébographie orbitaire. [Progress in the technic of orbital phlebography]. J Radiol Electrol Med Nucl. 1970 Jan-Feb;51(1):60-2. French. PMID: 5498169.
Copy Download .nbib Format: NLM
Psychology of the scientist: XVII. Research has a place in private practice.

Psychological reports

Meltzer H.
PMID: 5912813
Psychol Rep. 1966 Oct;19(2):463-72. doi: 10.2466/pr0.1966.19.2.463.

No abstract available.

Cite
Meltzer H. Psychology of the scientist: XVII. Research has a place in private practice. Psychol Rep. 1966;19(2):463-72doi: 10.2466/pr0.1966.19.2.463.
Meltzer, H. (1966). Psychology of the scientist: XVII. Research has a place in private practice. Psychological reports, 19(2), 463-72. https://doi.org/10.2466/pr0.1966.19.2.463
Meltzer, H. "Psychology of the scientist: XVII. Research has a place in private practice." Psychological reports vol. 19,2 (1966): 463-72. doi: https://doi.org/10.2466/pr0.1966.19.2.463
Meltzer H. Psychology of the scientist: XVII. Research has a place in private practice. Psychol Rep. 1966 Oct;19(2):463-72. doi: 10.2466/pr0.1966.19.2.463. PMID: 5912813.
Copy Download .nbib Format: NLM
Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter.

Optics express

Prinz S, Häfner M, Schultze M, Teisset CY, Bessing R, Michel K, Kienberger R, Metzger T.
PMID: 25607054
Opt Express. 2014 Dec 15;22(25):31050-6. doi: 10.1364/OE.22.031050.

Short-pulse-pumped optical parametric chirped pulse amplification (OPCPA) requires a precise temporal overlap of the interacting pulses in the nonlinear crystal to achieve stable performance. We present active synchronization of the ps-pump pulses and the broadband seed pulses used in...

Cite
Prinz S, Häfner M, Schultze M, et al. Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Opt Express. 2014;22(25):31050-6doi: 10.1364/OE.22.031050.
Prinz, S., Häfner, M., Schultze, M., Teisset, C. Y., Bessing, R., Michel, K., Kienberger, R., & Metzger, T. (2014). Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Optics express, 22(25), 31050-6. https://doi.org/10.1364/OE.22.031050
Prinz, Stephan, et al. "Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter." Optics express vol. 22,25 (2014): 31050-6. doi: https://doi.org/10.1364/OE.22.031050
Prinz S, Häfner M, Schultze M, Teisset CY, Bessing R, Michel K, Kienberger R, Metzger T. Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Opt Express. 2014 Dec 15;22(25):31050-6. doi: 10.1364/OE.22.031050. PMID: 25607054.
Copy Download .nbib Format: NLM
New perspectives on interdisciplinary earth science at the Dead Sea: The DESERVE project.

The Science of the total environment

Kottmeier C, Agnon A, Al-Halbouni D, Alpert P, Corsmeier U, Dahm T, Eshel A, Geyer S, Haas M, Holohan E, Kalthoff N, Kishcha P, Krawczyk C, Lati J, Laronne JB, Lott F, Mallast U, Merz R, Metzger J, Mohsen A, Morin E, Nied M, Rödiger T, Salameh E, Sawarieh A, Shannak B, Siebert C, Weber M.
PMID: 26779955
Sci Total Environ. 2016 Feb 15;544:1045-58. doi: 10.1016/j.scitotenv.2015.12.003. Epub 2016 Jan 09.

The Dead Sea region has faced substantial environmental challenges in recent decades, including water resource scarcity, ~1m annual decreases in the water level, sinkhole development, ascending-brine freshwater pollution, and seismic disturbance risks. Natural processes are significantly affected by human...

Cite
Kottmeier C, Agnon A, Al-Halbouni D, et al. New perspectives on interdisciplinary earth science at the Dead Sea: The DESERVE project. Sci Total Environ. 2016;544:1045-58doi: 10.1016/j.scitotenv.2015.12.003.
Kottmeier, C., Agnon, A., Al-Halbouni, D., Alpert, P., Corsmeier, U., Dahm, T., Eshel, A., Geyer, S., Haas, M., Holohan, E., Kalthoff, N., Kishcha, P., Krawczyk, C., Lati, J., Laronne, J. B., Lott, F., Mallast, U., Merz, R., Metzger, J., Mohsen, A., Morin, E., Nied, M., Rödiger, T., Salameh, E., Sawarieh, A., Shannak, B., Siebert, C., & Weber, M. (2016). New perspectives on interdisciplinary earth science at the Dead Sea: The DESERVE project. The Science of the total environment, 5441045-58. https://doi.org/10.1016/j.scitotenv.2015.12.003
Kottmeier, Christoph, et al. "New perspectives on interdisciplinary earth science at the Dead Sea: The DESERVE project." The Science of the total environment vol. 544 (2016): 1045-58. doi: https://doi.org/10.1016/j.scitotenv.2015.12.003
Kottmeier C, Agnon A, Al-Halbouni D, Alpert P, Corsmeier U, Dahm T, Eshel A, Geyer S, Haas M, Holohan E, Kalthoff N, Kishcha P, Krawczyk C, Lati J, Laronne JB, Lott F, Mallast U, Merz R, Metzger J, Mohsen A, Morin E, Nied M, Rödiger T, Salameh E, Sawarieh A, Shannak B, Siebert C, Weber M. New perspectives on interdisciplinary earth science at the Dead Sea: The DESERVE project. Sci Total Environ. 2016 Feb 15;544:1045-58. doi: 10.1016/j.scitotenv.2015.12.003. Epub 2016 Jan 09. PMID: 26779955.
Copy Download .nbib Format: NLM
Constructing tailored parental monitoring strategy profiles to predict adolescent disclosure and risk involvement.

Preventive medicine reports

Cottrell LA, Lilly CA, Metzger A, Cottrell SA, Epperly AD, Rishel C, Wang B, Stanton BF.
PMID: 28660123
Prev Med Rep. 2017 Jun 10;7:147-151. doi: 10.1016/j.pmedr.2017.06.001. eCollection 2017 Sep.

•Many parents use multiple monitoring strategies in different combinations over time to monitor their adolescents.•Adolescents of parents who use multiple strategies reported greater risk involvement.•Parents who solicited information only from adolescents had greater knowledge and adolescent disclosure.

Cite
Cottrell LA, Lilly CA, Metzger A, et al. Constructing tailored parental monitoring strategy profiles to predict adolescent disclosure and risk involvement. Prev Med Rep. 2017;7:147-151doi: 10.1016/j.pmedr.2017.06.001.
Cottrell, L. A., Lilly, C. A., Metzger, A., Cottrell, S. A., Epperly, A. D., Rishel, C., Wang, B., & Stanton, B. F. (2017). Constructing tailored parental monitoring strategy profiles to predict adolescent disclosure and risk involvement. Preventive medicine reports, 7147-151. https://doi.org/10.1016/j.pmedr.2017.06.001
Cottrell, Lesley A, et al. "Constructing tailored parental monitoring strategy profiles to predict adolescent disclosure and risk involvement." Preventive medicine reports vol. 7 (2017): 147-151. doi: https://doi.org/10.1016/j.pmedr.2017.06.001
Cottrell LA, Lilly CA, Metzger A, Cottrell SA, Epperly AD, Rishel C, Wang B, Stanton BF. Constructing tailored parental monitoring strategy profiles to predict adolescent disclosure and risk involvement. Prev Med Rep. 2017 Jun 10;7:147-151. doi: 10.1016/j.pmedr.2017.06.001. eCollection 2017 Sep. PMID: 28660123; PMCID: PMC5480979.
Copy Download .nbib Format: NLM
Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease.

Kidney international reports

Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, Massy ZA, Stengel B.
PMID: 29142956
Kidney Int Rep. 2016 Oct 31;2(2):180-191. doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar.

INTRODUCTION: Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown.METHODS: We studied 10-year mortality and cardiovascular events according to hypertension control...

Cite
Kaboré J, Metzger M, Helmer C, et al. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep. 2016;2(2):180-191doi: 10.1016/j.ekir.2016.10.006.
Kaboré, J., Metzger, M., Helmer, C., Berr, C., Tzourio, C., Drueke, T. B., Massy, Z. A., & Stengel, B. (2017). Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney international reports, 2(2), 180-191. https://doi.org/10.1016/j.ekir.2016.10.006
Kaboré, Jean, et al. "Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease." Kidney international reports vol. 2,2 (2017): 180-191. doi: https://doi.org/10.1016/j.ekir.2016.10.006
Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, Massy ZA, Stengel B. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep. 2016 Oct 31;2(2):180-191. doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar. PMID: 29142956; PMCID: PMC5678838.
Copy Download .nbib Format: NLM
VOC emission rates over London and South East England obtained by airborne eddy covariance.

Faraday discussions

Vaughan AR, Lee JD, Shaw MD, Misztal PK, Metzger S, Vieno M, Davison B, Karl TG, Carpenter LJ, Lewis AC, Purvis RM, Goldstein AH, Hewitt CN.
PMID: 28580967
Faraday Discuss. 2017 Aug 24;200:599-620. doi: 10.1039/c7fd00002b.

Volatile organic compounds (VOCs) originate from a variety of sources, and play an intrinsic role in influencing air quality. Some VOCs, including benzene, are carcinogens and so directly affect human health, while others, such as isoprene, are very reactive...

Cite
Vaughan AR, Lee JD, Shaw MD, et al. VOC emission rates over London and South East England obtained by airborne eddy covariance. Faraday Discuss. 2017;200:599-620doi: 10.1039/c7fd00002b.
Vaughan, A. R., Lee, J. D., Shaw, M. D., Misztal, P. K., Metzger, S., Vieno, M., Davison, B., Karl, T. G., Carpenter, L. J., Lewis, A. C., Purvis, R. M., Goldstein, A. H., & Hewitt, C. N. (2017). VOC emission rates over London and South East England obtained by airborne eddy covariance. Faraday discussions, 200599-620. https://doi.org/10.1039/c7fd00002b
Vaughan, Adam R, et al. "VOC emission rates over London and South East England obtained by airborne eddy covariance." Faraday discussions vol. 200 (2017): 599-620. doi: https://doi.org/10.1039/c7fd00002b
Vaughan AR, Lee JD, Shaw MD, Misztal PK, Metzger S, Vieno M, Davison B, Karl TG, Carpenter LJ, Lewis AC, Purvis RM, Goldstein AH, Hewitt CN. VOC emission rates over London and South East England obtained by airborne eddy covariance. Faraday Discuss. 2017 Aug 24;200:599-620. doi: 10.1039/c7fd00002b. PMID: 28580967.
Copy Download .nbib Format: NLM
Maternal and infant infections stimulate a rapid leukocyte response in breastmilk.

Clinical & translational immunology

Hassiotou F, Hepworth AR, Metzger P, Tat Lai C, Trengove N, Hartmann PE, Filgueira L.
PMID: 25505951
Clin Transl Immunology. 2013 Apr 12;2(4):e3. doi: 10.1038/cti.2013.1. eCollection 2013 Apr.

Breastmilk protects infants against infections; however, specific responses of breastmilk immune factors to different infections of either the mother or the infant are not well understood. Here, we examined the baseline range of breastmilk leukocytes and immunomodulatory biomolecules in...

Cite
Hassiotou F, Hepworth AR, Metzger P, et al. Maternal and infant infections stimulate a rapid leukocyte response in breastmilk. Clin Transl Immunology. 2013;2(4):e3doi: 10.1038/cti.2013.1.
Hassiotou, F., Hepworth, A. R., Metzger, P., Tat Lai, C., Trengove, N., Hartmann, P. E., & Filgueira, L. (2013). Maternal and infant infections stimulate a rapid leukocyte response in breastmilk. Clinical & translational immunology, 2(4), e3. https://doi.org/10.1038/cti.2013.1
Hassiotou, Foteini, et al. "Maternal and infant infections stimulate a rapid leukocyte response in breastmilk." Clinical & translational immunology vol. 2,4 (2013): e3. doi: https://doi.org/10.1038/cti.2013.1
Hassiotou F, Hepworth AR, Metzger P, Tat Lai C, Trengove N, Hartmann PE, Filgueira L. Maternal and infant infections stimulate a rapid leukocyte response in breastmilk. Clin Transl Immunology. 2013 Apr 12;2(4):e3. doi: 10.1038/cti.2013.1. eCollection 2013 Apr. PMID: 25505951; PMCID: PMC4232055.
Copy Download .nbib Format: NLM
CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power.

Optics express

Prinz S, Haefner M, Teisset CY, Bessing R, Michel K, Lee Y, Geng XT, Kim S, Kim DE, Metzger T, Schultze M.
PMID: 25835897
Opt Express. 2015 Jan 26;23(2):1388-94. doi: 10.1364/OE.23.001388.

We report on a CEP-stable OPCPA system reaching multi-GW peak powers at 300 kHz repetition rate. It delivers 15 W of average power, over 50 µJ of compressed pulse energy and a pulse duration below 6 fs. By implementing...

Cite
Prinz S, Haefner M, Teisset CY, et al. CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Opt Express. 2015;23(2):1388-94doi: 10.1364/OE.23.001388.
Prinz, S., Haefner, M., Teisset, C. Y., Bessing, R., Michel, K., Lee, Y., Geng, X. T., Kim, S., Kim, D. E., Metzger, T., & Schultze, M. (2015). CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Optics express, 23(2), 1388-94. https://doi.org/10.1364/OE.23.001388
Prinz, Stephan, et al. "CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power." Optics express vol. 23,2 (2015): 1388-94. doi: https://doi.org/10.1364/OE.23.001388
Prinz S, Haefner M, Teisset CY, Bessing R, Michel K, Lee Y, Geng XT, Kim S, Kim DE, Metzger T, Schultze M. CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Opt Express. 2015 Jan 26;23(2):1388-94. doi: 10.1364/OE.23.001388. PMID: 25835897.
Copy Download .nbib Format: NLM
Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts.

Electrophoresis

Kotz S, Kullmann M, Crone B, Kalayda GV, Jaehde U, Metzger S.
PMID: 26250553
Electrophoresis. 2015 Nov;36(21):2811-2819. doi: 10.1002/elps.201500188. Epub 2015 Sep 22.

Cisplatin is one of the most widely used anticancer agents, but a major problem for successful chemotherapy is the development of drug resistance of tumor cells against cisplatin. Resistance to cisplatin is a multifactorial problem. A method to detect...

Cite
Kotz S, Kullmann M, Crone B, et al. Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts. Electrophoresis. 2015;36(21):2811-2819doi: 10.1002/elps.201500188.
Kotz, S., Kullmann, M., Crone, B., Kalayda, G. V., Jaehde, U., & Metzger, S. (2015). Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts. Electrophoresis, 36(21), 2811-2819. https://doi.org/10.1002/elps.201500188
Kotz, Sandra, et al. "Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts." Electrophoresis vol. 36,21 (2015): 2811-2819. doi: https://doi.org/10.1002/elps.201500188
Kotz S, Kullmann M, Crone B, Kalayda GV, Jaehde U, Metzger S. Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adducts. Electrophoresis. 2015 Nov;36(21):2811-2819. doi: 10.1002/elps.201500188. Epub 2015 Sep 22. PMID: 26250553.
Copy Download .nbib Format: NLM
Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.

BMJ open diabetes research & care

Garg R, Schuman B, Hurwitz S, Metzger C, Bhandari S.
PMID: 28405346
BMJ Open Diabetes Res Care. 2017 Mar 29;5(1):e000394. doi: 10.1136/bmjdrc-2017-000394. eCollection 2017.

OBJECTIVE: To evaluate whether saxagliptin is non-inferior to basal-bolus insulin therapy for glycemic control in patients with controlled type 2 diabetes mellitus (T2DM) admitted to hospital with non-critical illnesses.RESEARCH DESIGN AND METHODS: This was an open-label, randomized controlled clinical...

Cite
Garg R, Schuman B, Hurwitz S, et al. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care. 2017;5(1):e000394doi: 10.1136/bmjdrc-2017-000394.
Garg, R., Schuman, B., Hurwitz, S., Metzger, C., & Bhandari, S. (2017). Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ open diabetes research & care, 5(1), e000394. https://doi.org/10.1136/bmjdrc-2017-000394
Garg, Rajesh, et al. "Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients." BMJ open diabetes research & care vol. 5,1 (2017): e000394. doi: https://doi.org/10.1136/bmjdrc-2017-000394
Garg R, Schuman B, Hurwitz S, Metzger C, Bhandari S. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care. 2017 Mar 29;5(1):e000394. doi: 10.1136/bmjdrc-2017-000394. eCollection 2017. PMID: 28405346; PMCID: PMC5372055.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 505 entries